GEA's wide range of container blenders offers the most flexible and highest quality blending solutions available today.
Container blending is recognised as being the most cost-effective and productive method of blending granules and powders in the pharmaceutical manufacturing process. Reduced loading and unloading times, reduced cleaning times — both machinery and room — improved containment and batch integrity have established container (IBC) blending as the pharmaceutical industry’s technology of choice.
R&D, small-scale and full-scale pharmaceutical production blenders provide simple transfer of process technology during scale-up, thus minimizing process validation activity.
This is fully supported by GEA's detailed research programme and testing facilities. Hoist- and pedestal-mounted versions are available as well as through-the-wall designs, which offer significant room layout benefits.
Since 2019, GEA has risen from underperformer to DAX member – one of Germany's top 40 listed companies – by fostering entrepreneurship and turning sustainability into a competitive advantage. It reached this milestone in its nearly 145-year history without tailwinds or shortcuts, in a world of compounding crises. This turnaround shows what's possible when purpose and performance align.
This year was a big one for GEA. Can you remember all the milestones and highlights?
The GEA Foundation launched this year with a promise: to make a tangible difference in people's lives. From scholarships in Germany to clean water in Tanzania, the foundation is already proving that when companies commit to giving back, lives change.